The earnings surpassed analyst expectations with an adjusted earnings per share (EPS) of $1.19, beating estimates of $0.91 by ...

Shareholders will be ecstatic, with their stake up 22% over the past week following CVS Health Corporation's (NYSE:CVS) ...

CVS Health (NYSE:CVS – Free Report) had its price target lifted by JPMorgan Chase & Co. from $80.00 to $81.00 in a report ...

Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance ...

Blue Trust Inc. decreased its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 14.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm ...

CEO David Joyner highlighted the company's Q4 adjusted EPS of $1.19 and adjusted operating income of $2.7 billion. He introduced 2025 adjusted EPS guidance of $5.75 to $6.00, emphasizing recovery in ...

Q4 2024 Earnings Call Transcript February 12, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.19, ...

Shares of CVS Health Corporation (NYSE: CVS) experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's ...

CVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — Aetna's turnaround.

Looking ahead, CVS Health's management forecasts an adjusted EPS range of $5.75 to $6.00 for 2025, expecting enhancements in financial results as value-based initiatives and digital investments ...